Calaspargase Pegol

CHEMBL2108728 Phase 4 Approuvé Enzyme

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A pegylated form of the enzyme asparaginase used in combination chemotherapy to treat acute lymphoblastic leukemia in children and young adults. It works by depleting asparagine, an amino acid that leukemia cells cannot produce themselves, causing them to die. Its long-acting pegylated form allows less frequent dosing than non-pegylated asparaginase.

Aires thérapeutiques

Pancreatic Cancer Lymphoma Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A pegylated form of the enzyme asparaginase used in combination chemotherapy to treat acute lymphoblastic leukemia in children and young adults. It works by depleting asparagine, an amino acid that leukemia cells cannot produce themselves, causing them to die. Its long-acting pegylated form allows less frequent dosing than non-pegylated asparaginase.

Yes, Calaspargase Pegol is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108728. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Calaspargase Pegol sur PillFYI

Données Clés

Synonymes: 1

Liens externes

ChEMBL CHEMBL2108728

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.